Novozymes aims to grow bioenergy with yeast and more business in Brazil
Novozymes is banking on larger sales of its yeast product Innova and deeper penetration into the Latin American market creating growth for the bioenergy division in 2020. However, the business area is simply bound to high uncertainty, says CFO Lars Green.
The stage was set for a real nightmarish read from Novozymes when the Danish enzyme maker presented its annual financial statement Thursday morning.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novozymes finishes difficult 2019 burdened by bioenergy
For subscribers
Novozymes appoints new CEO
For subscribers
